Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Combatting Lyme disease myths and the “chronic Lyme industry”

Wendy Glauser
CMAJ October 07, 2019 191 (40) E1111-E1112; DOI: https://doi.org/10.1503/cmaj.1095806
Wendy Glauser
Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

This article has a correction. Please see:

  • Combatting Lyme disease myths and the “chronic Lyme industry” - December 16, 2019

Medical organizations are developing tools to help Canadian doctors talk to patients about Lyme disease at a time when many frontline physicians report feeling ill-prepared to counter misinformation about the condition and pressured to send patients for Lyme testing and prescribe antibiotics when they aren’t warranted.

When Dr. Lynora Saxinger, an infectious disease specialist and associate professor at the University of Alberta’s medical school, recently conducted an informal survey of mostly primary care physicians, 30% said they have been pressured to give antibiotics and almost 90% said they didn’t feel they had appropriate educational resources to offer patients. (She posed the questions to a group of Canadian doctors online and 71 responded.) Health providers in Reddit chats share concerns and frustrations about patients overly concerned about Lyme, often in cases of extremely low possibility.

“It is difficult to counter some of the misinformation about Lyme, because it’s spread on websites that actually look very legitimate and very professional and there’s enough misinformation out there that it kind of cross-references itself,” says Saxinger.

Some of the common misconceptions include that there’s a high likelihood of getting Lyme from tick bites everywhere (not just in endemic areas), and that doctors lack up-to-date information about Lyme disease’s spread. (Across Canada, public health scientists conduct surveys every year).

Meanwhile, patients are getting more concerned about Lyme because of horror stories of “chronic Lyme.” Some advocacy groups argue that Lyme-causing bacteria continue to wreak havoc after treatment, but this position isn’t backed by evidence or supported by mainstream medical organizations. “There is an increasing number of people who have bought into the chronic Lyme industry,” says Saxinger.

Figure

Many people bitten by ticks panic and request treatment for Lyme disease prematurely.

Image courtesy of iStock.com/gabort71

When Dr. Michelle Cohen started practising in eastern Ontario in 2012, “people would come in with ticks attached but they weren’t pushing for treatment. They weren’t as upset about what that might mean.” These days, however, patients bitten by ticks often panic and request antibiotics right away. “People have heard these horrible stories about how Lyme is so awful and you suffer for years and years and nobody knows what’s wrong with you.”

This year, for the first time, her local public health department sent pamphlets for patients that included step-by-step charts of what to do after finding a tick, including which symptoms to look for and when to test. “Up until then, I’d only seen very clinical-facing guidelines and we’re supposed to explain that to patients and it’s confusing to explain all the complexities.”

Doctors have to communicate why it takes at least 24 hours of a tick being attached for the bacteria to be transmitted, why testing isn’t accurate in early stages, why Lyme is unlikely to be acquired from tick bites in most parts of Canada, and more.

The Centre for Effective Practice is developing clinician toolkits to help providers recognize and treat early Lyme disease, as well as patient-facing information to communicate the risks and effectiveness of testing and treatment. Dr. Todd Hatchette, president of the Association of Medical Microbiology and Infectious Disease, is a member of a working group involved in the development of the toolkits. He says that counselling patients about Lyme disease can take more time than physicians have in a busy clinic.

Testing is an option for patients with symptoms consistent with Lyme for four or more weeks, but “diagnosing early infection is more of a challenge,” he says, especially when patients can’t identify an expanding rash. “There are a lot of things that can cause nonspecific febrile illness.”

Another common misconception is that Lyme disease snowballs unless treated early, so it can be difficult to convince patients to wait several weeks to see if symptoms resolve before taking tests, says Hatchette. It can be reassuring to reiterate, however, that waiting doesn’t increase the low risk of post-Lyme disease syndrome. “There are no data I’m aware of that waiting for four weeks and treating at that time if the symptoms are positive means that antibiotics are any less effective.”

Although it can be tempting to allay patients’ concerns by providing prophylactic antibiotics after tick bites, if the practice becomes widespread, “the accumulated antibiotic risk exceeds the potential benefit by quite a bit; even though it’s a single dose of doxycycline, people can have severe drug reactions and it feeds an error-based myth as well,” says Saxinger.

To help combat myths about Lyme, future patient-facing pamphlets and campaigns should address the misconceptions directly, says Saxinger. “Patients may feel the information they themselves found, which always seems to be especially noteworthy if you’ve found it yourself, is not being accounted for.”

Footnotes

  • Posted on cmajnews.com on Sept. 17, 2019

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 191 (40)
CMAJ
Vol. 191, Issue 40
7 Oct 2019
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Combatting Lyme disease myths and the “chronic Lyme industry”
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Combatting Lyme disease myths and the “chronic Lyme industry”
Wendy Glauser
CMAJ Oct 2019, 191 (40) E1111-E1112; DOI: 10.1503/cmaj.1095806

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Combatting Lyme disease myths and the “chronic Lyme industry”
Wendy Glauser
CMAJ Oct 2019, 191 (40) E1111-E1112; DOI: 10.1503/cmaj.1095806
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Combatting Lyme disease myths and the “chronic Lyme industry”
  • PubMed
  • Google Scholar

Cited By...

  • Combatting Lyme disease myths and the "chronic Lyme industry"
  • Google Scholar

More in this TOC Section

  • Resignations at Canada’s drug pricing panel raise independence questions
  • Provinces accept federal health funding deal
  • Feds propose $196B health funding deal with few strings attached
Show more News

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire